Chemists in Ahmedabad to call shutter down before 11pm Ruby Khatun Khatun6 April 2018 10:43 AM ISTAHMEDABAD: Most of the chemists across Ahmedabad have taken a collective call to shut shop before 11 pm in order to make time for their families and...
Glenmark to market Helsinn's chemo-induced nausea drug in India, Nepal Ruby Khatun Khatun6 April 2018 10:30 AM ISTMumbai: Glenmark Pharmaceuticals announced that it has entered into an exclusive licensing agreement with Swiss firm Helsinn Group to introduce...
UK MHRA completes inspection of Lupin's Goa plant Ruby Khatun Khatun6 April 2018 10:05 AM ISTNew Delhi: Pharma major Lupin said the UK health regulator has completed the inspection of its Goa facility without making any critical...
Eli Lilly Cyramza succeeds in late-stage liver cancer trial Ruby Khatun Khatun6 April 2018 9:30 AM ISTEli Lilly and Co’s cancer drug Cyramza helped patients with liver cancer live longer, meeting the main goal of a late-stage trial, four years after...
Suven Life gets product patent from Canada Ruby Khatun Khatun5 April 2018 10:45 AM ISTNew Delhi: Suven Life Sciences said that it has been granted a product patent by Canada corresponding to New Chemical Entities (NCEs) for the...
Roche launches new lung, bladder cancer drug in India Ruby Khatun Khatun5 April 2018 10:34 AM ISTNew Delhi: Global pharma major Roche said it has launched monoclonal antibody atezolizumab under the brand name Tecentriq in India for treatment of...
Pharma may see recovery with FY19 profit set to jump 20-22 percent: Crisil Ruby Khatun Khatun5 April 2018 10:15 AM ISTNew Delhi: After a bruising two years, the domestic pharmaceutical sector is set for a sharp turnaround in the new fiscal year with a 20-22 percent...
GE Healthcare to sell IT unit to Veritas for 1.05 billion Ruby Khatun Khatun5 April 2018 9:45 AM ISTGeneral Electric Co's healthcare unit said it would sell its information technology business to private equity firm Veritas Capital for $1.05 billion...
Pfizer in deal with Allogene to develop cancer cell therapies Ruby Khatun Khatun5 April 2018 9:30 AM ISTPfizer Inc said it would take a 25 percent stake in Allogene Therapeutics to accelerate the development of CAR T cell therapies sourced from donors...
Dr Reddy's, Promius Pharma file NDA for migraine candidate Ruby Khatun Khatun4 April 2018 10:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd and its subsidiary, Promius Pharma, LLC announced the filing of New Drug Application (NDA) for its migraine...
Substandard and falsified medical products may cause harm to patients Ruby Khatun Khatun4 April 2018 10:15 AM ISTKolkata: Substandard and falsified medical products may cause harm to patients and fail to treat the diseases for which they were intended.Falsified...
European Medicines Agency to review Sanofi-Regeneron's Dupixent, Cemiplimab Ruby Khatun Khatun4 April 2018 9:45 AM ISTPARIS: The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and...
